Application of high resolution melting (HRM) analysis in detection of PDGFRA gene mutations among chronic myeloid leukemia patients treated with imanitib mesylate
A molecular detection of PDGFRA variants is highly relevant for prognosis and therapy prediction in chronic myeloid leukemia (CML) patients treated with Imatinib mesylate (IM). Even though IM has shown an excellent efficacy as a frontline treatment in CML, emerging of resistance towards IM in som...
| Main Author: | Rashid, Nur Sabrina Abd |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2020
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/49465/ http://eprints.usm.my/49465/1/Nur%20Sabrina%20Abd%20Rashid-24%20pages.pdf |
Similar Items
Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
by: Razali, Ruzi Hamimi
Published: (2015)
by: Razali, Ruzi Hamimi
Published: (2015)
Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah, et al.
Published: (2012)
by: Elias, Marjanu Hikmah, et al.
Published: (2012)
Imatinab mesylate treatment in Chronic Myeloid
Leukemia (CML)- understanding the
fundamental pharmacokinetic and
pharmacogenetic mechanisms for variation in
response
by: Ankathil, Ravindran
Published: (2016)
by: Ankathil, Ravindran
Published: (2016)
Molecular genetic and epigenetic mechanisms of primary and secondary resistance to imatinib mesylate treatment in ph chromosome positive chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah
Published: (2015)
by: Elias, Marjanu Hikmah
Published: (2015)
Genetic determinants excluding GBCR::ABL
mutations of imatinib mesylate therapy
response among chronic myeloid
leukaemia patients in Malaysia
by: Ismail, Siti Mariam
Published: (2023)
by: Ismail, Siti Mariam
Published: (2023)
Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients
by: Mardziah M,, et al.
Published: (2019)
by: Mardziah M,, et al.
Published: (2019)
Influence of tert gene expression, telomerase activity and telomere length in relation to imatinib mesylate resistance in Malaysian chronic myeloid leukaemia patients
by: Shamshudin, Wati @ Hayati Mohd
Published: (2020)
by: Shamshudin, Wati @ Hayati Mohd
Published: (2020)
Determination of gene copy number status in tert and terc among chronic myeloid leukaemia patients resist ant and responsive to imatinib mesylate treatment
by: Asrari, Zaidatul Shakila Mohamad
Published: (2014)
by: Asrari, Zaidatul Shakila Mohamad
Published: (2014)
TILLING, high-resolution melting (HRM), and next-generation sequencing (NGS) techniques in plant mutation breeding
by: Taheri, Sima, et al.
Published: (2017)
by: Taheri, Sima, et al.
Published: (2017)
Eccentricity of Acute Myeloid Leukemia with NPM1 and FLT3-ITD mutation: a case report
by: Nur Zainura Mohamad,, et al.
Published: (2022)
by: Nur Zainura Mohamad,, et al.
Published: (2022)
Analysis of SSR markers linked with brown planthopper resistance genes (Bph) using high-resolution melting (HRM) in rice
by: Shabanimofrad, Mahmoodreza, et al.
Published: (2015)
by: Shabanimofrad, Mahmoodreza, et al.
Published: (2015)
Influence of ORM1, PXR, CAR, CYP3A4 and CYP3A5 gene polymorphisms in mediating susceptibility risk to chronic myeloid leukaemia and response to imatinib mesylate therapy
by: Maddin, Najlaa
Published: (2017)
by: Maddin, Najlaa
Published: (2017)
Targeted RNAi of the mitogen-activated protein kinase pathway
genes in acute myeloid leukemia cells
by: Mohd Hafiz, M.R., et al.
Published: (2013)
by: Mohd Hafiz, M.R., et al.
Published: (2013)
Subtractive hybridization identifies stem cell-associated genes in an acute myeloid leukemia with poor prognosis
by: Ngiow, Shin Foong, et al.
Published: (2016)
by: Ngiow, Shin Foong, et al.
Published: (2016)
Imbalanced expression of polycistronic miRNA in acute myeloid leukemia
by: Kotaki, Ryutaro, et al.
Published: (2017)
by: Kotaki, Ryutaro, et al.
Published: (2017)
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
by: Ley, T., et al.
Published: (2013)
by: Ley, T., et al.
Published: (2013)
Real-Time High Resolution Melting Analysis-PCR for Assessment of Gene Mutations in Human Autosomal Dominant Polycystic Kidney Disease
by: Mohd Jas, Rusni
Published: (2011)
by: Mohd Jas, Rusni
Published: (2011)
Clinical evaluation and proteomic profiles of acute myeloid leukemia patients, Saudi Arabia
by: Almaiman, Amer Abdulrahman
Published: (2015)
by: Almaiman, Amer Abdulrahman
Published: (2015)
Effects of epigallocatechin-3-gallate (EGCG) on cell cycle distribution and DNA integrity of K562 cells, a human chronic myeloid leukemia
by: Elda Surhaida Latif,, et al.
Published: (2020)
by: Elda Surhaida Latif,, et al.
Published: (2020)
Proteomics profiling and genomics computational analysis of acute myeloid leukemia / Md. Mirazul Islam
by: Md. Mirazul, Islam
Published: (2017)
by: Md. Mirazul, Islam
Published: (2017)
Concomitant t(8;21) and trisomy 4 in a patient with Acute
Myeloid Leukemia (AML)
by: Phan CL,, et al.
Published: (2010)
by: Phan CL,, et al.
Published: (2010)
Analysis of Madm, a novel adaptor protein that associates with Myeloid Leukemia Factor 1
by: Lim, Raelene
Published: (2003)
by: Lim, Raelene
Published: (2003)
Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells
by: Alharbi, Raed A., et al.
Published: (2017)
by: Alharbi, Raed A., et al.
Published: (2017)
FLT3, NPM1, DNMT3a and NRAS genes mutation in acute myeloid leukaemia in HUSM
by: Mat Yunus, Noraini
Published: (2015)
by: Mat Yunus, Noraini
Published: (2015)
The Clinical Significance Of Npm1, Flt3 And Cebpa Gene Mutations In Adult Patients With Acute Myeloid Leukaemia
by: Ul Haq, Izaz
Published: (2020)
by: Ul Haq, Izaz
Published: (2020)
A composition for treating leukemia
by: Abdullah, Rasedee, et al.
Published: (2013)
by: Abdullah, Rasedee, et al.
Published: (2013)
Gene Expression, Biochemical And
Functional Analysis Of Stromal
Interaction Molecule 1 (Stim1) Silencing
In Acute Myeloid Leukemia Cell Lines
by: Algariri, Eman Salem Saeed
Published: (2022)
by: Algariri, Eman Salem Saeed
Published: (2022)
Molecular responses during chemotherapy in acute myeloid leukemias in predicting poor-response to standard chemotherapy.
by: Abdullah, Maha, et al.
Published: (2009)
by: Abdullah, Maha, et al.
Published: (2009)
Molecular basis of primary and secondary
resistance to imatinib mesylate
by: Abdul Aziz, Baba
Published: (2012)
by: Abdul Aziz, Baba
Published: (2012)
Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy
by: Young, Christine S., et al.
Published: (2017)
by: Young, Christine S., et al.
Published: (2017)
Cytotoxic Effects of Betulinic Acid and its Derivatives on Human Myeloid Leukemia (Hl-60) Cell Line
by: Faujan, Nur Hana
Published: (2008)
by: Faujan, Nur Hana
Published: (2008)
Ultra-high performance liquid chromatography
(uhplc) method development and validation for the
determination of serum imatinib and its active
metabolite concentration among chronic myeloid
leukemia patients
by: Liong, Tan Ka
Published: (2013)
by: Liong, Tan Ka
Published: (2013)
Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort
by: Ghassemifar, Reza, et al.
Published: (2011)
by: Ghassemifar, Reza, et al.
Published: (2011)
Development of the High Resolution Melt (HRM) method to detect the HLA-B*58:01 allele in order to prevent allopurinol-associated drug hypersensitivity
by: Nawoor, Anusha Devi
Published: (2022)
by: Nawoor, Anusha Devi
Published: (2022)
Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
by: Chen, Li-Chia, et al.
Published: (2014)
by: Chen, Li-Chia, et al.
Published: (2014)
Detection of eight common β-globin gene mutation in thalassemia major patients using real time polymerase chain reaction (PCR)-high resolution melting and EvaGreen™ dye
by: Marash, Seyed Jalal, et al.
Published: (2012)
by: Marash, Seyed Jalal, et al.
Published: (2012)
Screening of ARX, CDKL5 and STXBP1 gene mutations in Malaysian paediatric patients with early-onset epileptic encephalopathy by HRM technique
by: Jaafar, Ameerah
Published: (2015)
by: Jaafar, Ameerah
Published: (2015)
DNA damage response and anti-apoptotic proteins expression in NPMc+ mutated cells in acute myeloid leukaemia
by: Qutob, Haitham
Published: (2014)
by: Qutob, Haitham
Published: (2014)
A randomized control trial comparing peginterferon-α-2a versus observation after stopping tyrosine kinase inhibitor in chronic myeloid leukemia with deep molecular response for at least two years
by: Kuan, Jew-Win, et al.
Published: (2016)
by: Kuan, Jew-Win, et al.
Published: (2016)
Selection of reference genes for quantitative studies in acute myeloid leukaemia
by: Lee, Cindee, et al.
Published: (2019)
by: Lee, Cindee, et al.
Published: (2019)
Similar Items
-
Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
by: Razali, Ruzi Hamimi
Published: (2015) -
Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah, et al.
Published: (2012) -
Imatinab mesylate treatment in Chronic Myeloid
Leukemia (CML)- understanding the
fundamental pharmacokinetic and
pharmacogenetic mechanisms for variation in
response
by: Ankathil, Ravindran
Published: (2016) -
Molecular genetic and epigenetic mechanisms of primary and secondary resistance to imatinib mesylate treatment in ph chromosome positive chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah
Published: (2015) -
Genetic determinants excluding GBCR::ABL
mutations of imatinib mesylate therapy
response among chronic myeloid
leukaemia patients in Malaysia
by: Ismail, Siti Mariam
Published: (2023)